Nanoscale 2015-08-28

Differentiating sepsis from non-infectious systemic inflammation based on microvesicle-bacteria aggregation.

I K Herrmann, S Bertazzo, D J P O'Callaghan, A A Schlegel, C Kallepitis, D B Antcliffe, A C Gordon, M M Stevens

Index: Nanoscale 7 , 13511-20, (2015)

Full Text: HTML

Abstract

Sepsis is a severe medical condition and a leading cause of hospital mortality. Prompt diagnosis and early treatment has a significant, positive impact on patient outcome. However, sepsis is not always easy to diagnose, especially in critically ill patients. Here, we present a conceptionally new approach for the rapid diagnostic differentiation of sepsis from non-septic intensive care unit patients. Using advanced microscopy and spectroscopy techniques, we measure infection-specific changes in the activity of nano-sized cell-derived microvesicles to bind bacteria. We report on the use of a point-of-care-compatible microfluidic chip to measure microvesicle-bacteria aggregation and demonstrate rapid (≤1.5 hour) and reliable diagnostic differentiation of bacterial infection from non-infectious inflammation in a double-blind pilot study. Our study demonstrates the potential of microvesicle activities for sepsis diagnosis and introduces microvesicle-bacteria aggregation as a potentially useful parameter for making early clinical management decisions.

Related Compounds

Structure Name/CAS No. Articles
Ethanol Structure Ethanol
CAS:64-17-5
Hexamethyldisilazane Structure Hexamethyldisilazane
CAS:999-97-3
Formaldehyde Structure Formaldehyde
CAS:50-00-0
SodiuM bicarbonate Structure SodiuM bicarbonate
CAS:144-55-8
carbon black Structure carbon black
CAS:1333-86-4
SODIUM NITRILOTRIACETATE Structure SODIUM NITRILOTRIACETATE
CAS:5064-31-3
Disodium nitrilotriacetate Structure Disodium nitrilotriacetate
CAS:15467-20-6
glutaraldehyde Structure glutaraldehyde
CAS:111-30-8
Magnesium fluoride Structure Magnesium fluoride
CAS:7783-40-6
N,O-Bis(trimethylsilyl)acetamide Structure N,O-Bis(trimethylsilyl)acetamide
CAS:10416-59-8